Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment.

Shi S, Orbay H, Yang Y, Graves SA, Nayak TR, Hong H, Hernandez R, Luo H, Goel S, Theuer CP, Nickles RJ, Cai W.

J Nucl Med. 2015 Jun;56(6):927-32. doi: 10.2967/jnumed.114.153098. Epub 2015 Apr 16.

2.

Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy.

Chen F, Hong H, Shi S, Goel S, Valdovinos HF, Hernandez R, Theuer CP, Barnhart TE, Cai W.

Sci Rep. 2014 May 30;4:5080. doi: 10.1038/srep05080.

3.

Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105).

Toi H, Tsujie M, Haruta Y, Fujita K, Duzen J, Seon BK.

Int J Cancer. 2015 Jan 15;136(2):452-61. doi: 10.1002/ijc.28994. Epub 2014 Jun 13.

4.

Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging.

Guo J, Hong H, Chen G, Shi S, Nayak TR, Theuer CP, Barnhart TE, Cai W, Gong S.

ACS Appl Mater Interfaces. 2014 Dec 24;6(24):21769-79. doi: 10.1021/am5002585. Epub 2014 Mar 14.

5.

Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with (64)Cu-NOTA-TRC105.

Orbay H, Hong H, Koch JM, Valdovinos HF, Hacker TA, Theuer CP, Barnhart TE, Cai W.

Am J Transl Res. 2013 Dec 1;6(1):54-63. eCollection 2013.

6.

Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles.

Guo J, Hong H, Chen G, Shi S, Zheng Q, Zhang Y, Theuer CP, Barnhart TE, Cai W, Gong S.

Biomaterials. 2013 Nov;34(33):8323-8332. doi: 10.1016/j.biomaterials.2013.07.085. Epub 2013 Aug 8.

7.

Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.

Zhang Y, Hong H, Nayak TR, Valdovinos HF, Myklejord DV, Theuer CP, Barnhart TE, Cai W.

Angiogenesis. 2013 Jul;16(3):663-74. doi: 10.1007/s10456-013-9344-y. Epub 2013 Mar 8. Erratum in: Angiogenesis. 2013 Oct;16(4):993-4.

8.

PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragment.

Zhang Y, Hong H, Orbay H, Valdovinos HF, Nayak TR, Theuer CP, Barnhart TE, Cai W.

Eur J Nucl Med Mol Imaging. 2013 May;40(5):759-67. doi: 10.1007/s00259-012-2334-2. Epub 2013 Jan 24.

9.

Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment.

Hong H, Zhang Y, Orbay H, Valdovinos HF, Nayak TR, Bean J, Theuer CP, Barnhart TE, Cai W.

Mol Pharm. 2013 Feb 4;10(2):709-16. doi: 10.1021/mp300507r. Epub 2013 Jan 14.

10.

Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW.

Hong H, Zhang Y, Severin GW, Yang Y, Engle JW, Niu G, Nickles RJ, Chen X, Leigh BR, Barnhart TE, Cai W.

Mol Pharm. 2012 Aug 6;9(8):2339-49. doi: 10.1021/mp300277f. Epub 2012 Jul 19.

11.

A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer.

Rosen LS, Hurwitz HI, Wong MK, Goldman J, Mendelson DS, Figg WD, Spencer S, Adams BJ, Alvarez D, Seon BK, Theuer CP, Leigh BR, Gordon MS.

Clin Cancer Res. 2012 Sep 1;18(17):4820-9. doi: 10.1158/1078-0432.CCR-12-0098. Epub 2012 Jul 5.

12.

In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.

Hong H, Yang K, Zhang Y, Engle JW, Feng L, Yang Y, Nayak TR, Goel S, Bean J, Theuer CP, Barnhart TE, Liu Z, Cai W.

ACS Nano. 2012 Mar 27;6(3):2361-70. doi: 10.1021/nn204625e. Epub 2012 Feb 16.

13.

Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.

Zhang Y, Hong H, Engle JW, Yang Y, Theuer CP, Barnhart TE, Cai W.

Mol Pharm. 2012 Mar 5;9(3):645-53. doi: 10.1021/mp200592m. Epub 2012 Jan 31.

14.

Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.

Zhang Y, Hong H, Engle JW, Bean J, Yang Y, Leigh BR, Barnhart TE, Cai W.

PLoS One. 2011;6(12):e28005. doi: 10.1371/journal.pone.0028005. Epub 2011 Dec 9.

15.

Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.

Hong H, Severin GW, Yang Y, Engle JW, Zhang Y, Barnhart TE, Liu G, Leigh BR, Nickles RJ, Cai W.

Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):138-48. doi: 10.1007/s00259-011-1930-x. Epub 2011 Sep 10.

16.

In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis.

Yang Y, Zhang Y, Hong H, Liu G, Leigh BR, Cai W.

Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):2066-76. doi: 10.1007/s00259-011-1886-x. Epub 2011 Aug 4.

17.

Positron emission tomography imaging of CD105 expression during tumor angiogenesis.

Hong H, Yang Y, Zhang Y, Engle JW, Barnhart TE, Nickles RJ, Leigh BR, Cai W.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1335-43. doi: 10.1007/s00259-011-1765-5. Epub 2011 Mar 4.

18.

Endoglin-targeted cancer therapy.

Seon BK, Haba A, Matsuno F, Takahashi N, Tsujie M, She X, Harada N, Uneda S, Tsujie T, Toi H, Tsai H, Haruta Y.

Curr Drug Deliv. 2011 Jan;8(1):135-43. Review.

Supplemental Content

Loading ...
Support Center